es fr it za

Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir

A second major HIV prospect has been put on hold, this time from Gilead Sciences. But unlike the recent halt on Merck's drug islatravir, ...


View article...


Top stories of the last 30 days